New FDA Nitrosamine Guidelines: What Pharma Manufacturers Need to Know
The FDA has issued updated nitrosamine guidelines, significantly tightening requirements for risk assessment, testing, and acceptable intake levels. These changes have significant implications for pharmaceutical development, manufacturing, and regulatory compliance. Companies must act quickly to meet these new standards and avoid delays or recalls. Download the full article to learn how your organization can stay compliant and competitive under the revised FDA nitrosamine regulations.
Author: Shankar Sankaran, Executive Director of Analytical Services